Lindsay Harrison, MD authors study published in the Journal of Clinical Endocrinology & Metabolism
Texas Diabetes & Endocrinology physician Lindsay Harrison, MD authored a study that was recently published in the JCEM titled Mechanisms of Action of Liraglutide in Patients with Type 2 Diabetes Treated with High Dose Insulin.
The study concluded that Treatment with liraglutide significantly improved insulin secretion even in patients with long-standing T2D requiring high-dose insulin treatment. Liraglutide also decreased liver and subcutaneous fat, but did not alter glucagon secretion. – See more at: http://press.endocrine.org/doi/abs/10.1210/jc.2015-3906#sthash.rGdwKIl1.dpuf
Posted on April 10, 2018
Posted on September 18, 2017
Posted on July 17, 2017